A controlled trial of 5-hydroxy-L-tryptophan for ataxia in progressive myoclonus epilepsy

Clinical Neurology and Neurosurgery

Volumn 98, Issue 2, 1996, Pages 161-164

  Pranzatelli, M R ^a   Tate, E ^a   Galvan, I ^a   Wheeler, A ^a  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

Ataxia scale; Lafora disease; Mitochondrial encephalomyopathy; Serotonin; Unverricht Lundborg disease

Indexed keywords

5 HYDROXYTRYPTOPHAN; ANTIDEPRESSANT AGENT; CARBIDOPA; SEROTONIN;

ADOLESCENT; ADULT; ARTICLE; ATAXIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MALE; MOTOR PERFORMANCE; MYOCLONUS EPILEPSY; NEUROTRANSMISSION; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL;

EID: 0030152957     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/0303-8467(96)00014-5     Document Type: Article

References (8)

1. [1] Marseille Consensus Group (1990) Classification of progressive myoclonus epilepsies and related disorders. Ann. Neurol., 28: 113-116.
2. [2] Roger, J. (1990) Progressive myoclonus epilepsies. In: Dam, M. and Gram, L. (Eds.), Comprehensive Epileptology, Raven Press, New York, pp. 215-231.
3. [3] Pranzatelli, M.R., Tate, E., Huang, Y., Haas, R., Bodensteiner, J., Ashwal, S. and Franz, D. (1995) The neuropharmacology of progressive myoclonus epilepsy: response to 5-hydroxy-L-tryptophan. Epilepsia, 36: 783-791.
4. [4] Leino, E., MacDonald, E., Airaksinen, M.M., Riekkinen, P.J. and Salo, H. (1980) Homovanillic acid and 5-hydroxyindoleacetic acid levels in cerebrospinal fluid of patients with progressive myoclonus epilepsy. Acta. Neurol. Scand., 62: 41-54.
5. [5] Trouillas, P., Brudon, F. and Adeleine, P. (1988) Improvement of cerebellar ataxia with levorotatory form of 5-hydroxytryptophan. Arch. Neurol., 45: 1217-1222.
6. [6] Pranzatelli, M.R. (1994) Serotonin and human myoclonus: rationale for the use of serotoninreceptor agonists and antagonists. Arch. Neurol., 51: 605-617.
7. [7] Magnussen, I.B. and Van Woert, M.H. (1982) Human pharmacokinetics of long-term 5-hydroxytryptophan combined with decarboxylase inhibitors. Eur. J. Clin. Pharmacol., 23: 81-86.
8. [8] SAS Institute Inc. (1985) SAS User's Guide: Statistics, Version 5 Edition, SAS Institute, Inc., Cary, NC.